1. Home
  2. BLFS vs XPEL Comparison

BLFS vs XPEL Comparison

Compare BLFS & XPEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BLFS
  • XPEL
  • Stock Information
  • Founded
  • BLFS 1987
  • XPEL 1999
  • Country
  • BLFS United States
  • XPEL United States
  • Employees
  • BLFS N/A
  • XPEL N/A
  • Industry
  • BLFS Medical/Dental Instruments
  • XPEL Industrial Specialties
  • Sector
  • BLFS Health Care
  • XPEL Industrials
  • Exchange
  • BLFS Nasdaq
  • XPEL Nasdaq
  • Market Cap
  • BLFS 1.2B
  • XPEL 984.3M
  • IPO Year
  • BLFS 1989
  • XPEL N/A
  • Fundamental
  • Price
  • BLFS $26.31
  • XPEL $34.03
  • Analyst Decision
  • BLFS Strong Buy
  • XPEL
  • Analyst Count
  • BLFS 7
  • XPEL 0
  • Target Price
  • BLFS $30.86
  • XPEL N/A
  • AVG Volume (30 Days)
  • BLFS 356.3K
  • XPEL 289.6K
  • Earning Date
  • BLFS 11-11-2025
  • XPEL 11-06-2025
  • Dividend Yield
  • BLFS N/A
  • XPEL N/A
  • EPS Growth
  • BLFS N/A
  • XPEL 2.75
  • EPS
  • BLFS N/A
  • XPEL 1.76
  • Revenue
  • BLFS $93,468,000.00
  • XPEL $448,897,000.00
  • Revenue This Year
  • BLFS $26.07
  • XPEL $12.54
  • Revenue Next Year
  • BLFS $16.86
  • XPEL $10.52
  • P/E Ratio
  • BLFS N/A
  • XPEL $19.22
  • Revenue Growth
  • BLFS 68.16
  • XPEL 9.96
  • 52 Week Low
  • BLFS $19.10
  • XPEL $24.25
  • 52 Week High
  • BLFS $29.55
  • XPEL $47.23
  • Technical
  • Relative Strength Index (RSI)
  • BLFS 57.56
  • XPEL 47.81
  • Support Level
  • BLFS $24.33
  • XPEL $31.87
  • Resistance Level
  • BLFS $27.42
  • XPEL $35.02
  • Average True Range (ATR)
  • BLFS 0.89
  • XPEL 1.11
  • MACD
  • BLFS 0.08
  • XPEL 0.17
  • Stochastic Oscillator
  • BLFS 70.51
  • XPEL 66.86

About BLFS BioLife Solutions Inc.

BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.

About XPEL XPEL Inc.

XPEL Inc is a supplier of protective films, coatings, and related services to the automobile aftermarket, new car dealerships, and automobile original equipment manufacturers, or OEMs. The majority of its revenue is derived from the sale of automotive products and related services while the remainder of its revenue is derived from non-automotive products including architectural window film and marine and flat surface protection films. The majority of revenue is derived from the United States.

Share on Social Networks: